Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Organobismuth derivative contrast agent from Nissan Chemical

Aug. 23, 1996

Hematopoiesis-stimulating compounds from Nycomed Pharma

Aug. 23, 1996

New hypolipidemic agent from Schering-Plough

Aug. 23, 1996

Yamanouchi and PT CarbaPharma describe cathepsin L inhibitor

Aug. 23, 1996

Antineoplastic agents from Japan Energy

Aug. 23, 1996

Farnesyl transferase inhibitors from Pierre Fabre

Aug. 23, 1996

Immunomodulating peptides from BioChem Pharma

Aug. 23, 1996

Taiho discloses antitumor nucleoside drugs

Aug. 23, 1996

Cyclooxygenase-2-inhibitors described by Japan Tobacco

Aug. 23, 1996

Cyclooxygenase-2 inhibitors from Merck Frosst

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...